vs

Side-by-side financial comparison of Canaan Inc. (CAN) and CVRx, Inc. (CVRX). Click either name above to swap in a different company.

Canaan Inc. is the larger business by last-quarter revenue ($20.8M vs $16.0M, roughly 1.3× CVRx, Inc.). Canaan Inc. runs the higher net margin — -18.4% vs -74.5%, a 56.0% gap on every dollar of revenue.

Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

CAN vs CVRX — Head-to-Head

Bigger by revenue
CAN
CAN
1.3× larger
CAN
$20.8M
$16.0M
CVRX
Higher net margin
CAN
CAN
56.0% more per $
CAN
-18.4%
-74.5%
CVRX

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CAN
CAN
CVRX
CVRX
Revenue
$20.8M
$16.0M
Net Profit
$-3.8M
$-11.9M
Gross Margin
99.9%
86.3%
Operating Margin
-15.9%
-69.8%
Net Margin
-18.4%
-74.5%
Revenue YoY
4.4%
Net Profit YoY
-12.0%
EPS (diluted)
$-0.05
$-0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAN
CAN
CVRX
CVRX
Q4 25
$20.8M
$16.0M
Q3 25
$13.8M
$14.7M
Q2 25
$11.4M
$13.6M
Q1 25
$12.3M
Q4 24
$15.3M
Q3 24
$10.2M
$13.4M
Q2 24
$4.8M
$11.8M
Q1 24
$10.8M
Net Profit
CAN
CAN
CVRX
CVRX
Q4 25
$-3.8M
$-11.9M
Q3 25
$-1.5M
$-12.9M
Q2 25
$-11.9M
$-14.7M
Q1 25
$-13.8M
Q4 24
$-10.7M
Q3 24
$-10.4M
$-13.1M
Q2 24
$-5.4M
$-14.0M
Q1 24
$-22.2M
Gross Margin
CAN
CAN
CVRX
CVRX
Q4 25
99.9%
86.3%
Q3 25
99.9%
86.8%
Q2 25
99.9%
84.3%
Q1 25
83.5%
Q4 24
83.2%
Q3 24
99.9%
83.2%
Q2 24
99.8%
83.9%
Q1 24
85.0%
Operating Margin
CAN
CAN
CVRX
CVRX
Q4 25
-15.9%
-69.8%
Q3 25
-27.0%
-83.5%
Q2 25
-45.5%
-105.8%
Q1 25
-108.8%
Q4 24
-67.0%
Q3 24
-77.2%
-97.3%
Q2 24
-193.9%
-118.3%
Q1 24
-206.4%
Net Margin
CAN
CAN
CVRX
CVRX
Q4 25
-18.4%
-74.5%
Q3 25
-11.0%
-87.6%
Q2 25
-104.4%
-108.4%
Q1 25
-111.5%
Q4 24
-69.4%
Q3 24
-102.7%
-98.0%
Q2 24
-112.3%
-118.8%
Q1 24
-206.0%
EPS (diluted)
CAN
CAN
CVRX
CVRX
Q4 25
$-0.05
$-0.45
Q3 25
$-0.02
$-0.49
Q2 25
$-0.25
$-0.57
Q1 25
$-0.53
Q4 24
$-0.39
Q3 24
$-0.57
Q2 24
$-0.65
Q1 24
$-1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAN
CAN
CVRX
CVRX
Cash + ST InvestmentsLiquidity on hand
$75.7M
Total DebtLower is stronger
$6.2M
Stockholders' EquityBook value
$52.4M
$39.3M
Total Assets
$92.5M
$104.8M
Debt / EquityLower = less leverage
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAN
CAN
CVRX
CVRX
Q4 25
$75.7M
Q3 25
$85.1M
Q2 25
$95.0M
Q1 25
$102.7M
Q4 24
$105.9M
Q3 24
$100.2M
Q2 24
$70.4M
Q1 24
$80.1M
Total Debt
CAN
CAN
CVRX
CVRX
Q4 25
$6.2M
Q3 25
$6.2M
Q2 25
$6.2M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CAN
CAN
CVRX
CVRX
Q4 25
$52.4M
$39.3M
Q3 25
$44.7M
$48.1M
Q2 25
$33.8M
$57.9M
Q1 25
$71.1M
Q4 24
$71.1M
Q3 24
$43.6M
$65.2M
Q2 24
$56.8M
$55.2M
Q1 24
$66.3M
Total Assets
CAN
CAN
CVRX
CVRX
Q4 25
$92.5M
$104.8M
Q3 25
$81.7M
$111.3M
Q2 25
$78.0M
$119.6M
Q1 25
$129.6M
Q4 24
$133.4M
Q3 24
$69.3M
$127.7M
Q2 24
$73.7M
$96.0M
Q1 24
$106.2M
Debt / Equity
CAN
CAN
CVRX
CVRX
Q4 25
0.12×
Q3 25
0.14×
Q2 25
0.18×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAN
CAN
CVRX
CVRX
Operating Cash FlowLast quarter
$-9.8M
Free Cash FlowOCF − Capex
$-9.8M
FCF MarginFCF / Revenue
-61.3%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAN
CAN
CVRX
CVRX
Q4 25
$-9.8M
Q3 25
$-9.7M
Q2 25
$-7.9M
Q1 25
$-12.8M
Q4 24
$-8.0M
Q3 24
$-10.4M
Q2 24
$-9.8M
Q1 24
$-10.9M
Free Cash Flow
CAN
CAN
CVRX
CVRX
Q4 25
$-9.8M
Q3 25
$-10.0M
Q2 25
$-8.0M
Q1 25
$-12.9M
Q4 24
$-8.1M
Q3 24
$-10.4M
Q2 24
$-10.2M
Q1 24
$-11.8M
FCF Margin
CAN
CAN
CVRX
CVRX
Q4 25
-61.3%
Q3 25
-68.1%
Q2 25
-59.2%
Q1 25
-104.3%
Q4 24
-52.5%
Q3 24
-78.1%
Q2 24
-86.3%
Q1 24
-109.7%
Capex Intensity
CAN
CAN
CVRX
CVRX
Q4 25
0.4%
Q3 25
2.0%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
0.3%
Q3 24
0.3%
Q2 24
3.0%
Q1 24
8.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAN
CAN

Segment breakdown not available.

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

Related Comparisons